FDA moves toward easing restrictions on certain peptides BioPharma Dive FDA to Review 7 Peptides for Compounding List in July 2026: BPC 157, Semax, Epitalon, and More HealingMaps A new FDA advisory panel meeting, influenced by RFK Jr.'s push for broader access, will weigh the potential benefits and risks of widely promoted peptides. Click the link in bio to read BPC 157 Before and After: 1 Amazing Transformation Full article: Compounded glucagon like peptide 1 receptor agonists for weight loss: the direct to consumer market in Colorado FDA Targets GLP 1 and Peptide Compounding, Advertising and 'Research Use Only' Labeling